$460.28
-18.20-3.8%
Last update: Nov 5, 7:56 PM
Amgen Inc (AMGN) Stock Price, Quote, News & History
AMGNNASDAQ
Amgen approaches 52-week highs on Q3 earnings beats and raised 2026 guidance, while Wall Street analysts lift price targets.
You can purchase shares of Amgen (NASDAQ:AMGN) through any online brokerage.
Other companies in Amgen’s space includes: AbbVie Inc (NYSE:ABBV), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX), Moderna Inc (NASDAQ:MRNA) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Amgen has a consensus price target of $427.11.
The stock price for Amgen (NASDAQ: AMGN) is $458.6 last updated November 5, 2026 at 7:56 PM EST.
There are no upcoming dividends for Amgen.
Amgen does not have any upcoming earnings scheduled.
There is no upcoming split for Amgen.
Amgen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first...
